Biochemotherapy with low doses of subcutaneous interleukin-2 in patients with melanoma: Results of a phase II trial

1. Cao, M.G.
2. Puig, S.
3. Malvehy, J.
4. Herrero, J.E.
5. Martí, R.M.
6. Conill, C.
7. Sánchez, M.
8. Mellado, B.
9. Gascón, P.
10. Castel, T.